Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)

PHASE3CompletedINTERVENTIONAL
Enrollment

606

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Psoriatic Arthritis
Interventions
DRUG

Secukinumab (75 mg)

Secukinumab (75 mg)

DRUG

Secukinumab (150 mg)

Secukinumab (150 mg)

DRUG

Placebo Comparator

Placebo Comparator

Trial Locations (110)

1000

Novartis Investigative Site, Manila

1003

Novartis Investigative Site, Manila

Novartis Investigative Site, Manila

1008

Novartis Investigative Site, Manila

1102

Novartis Investigative Site, Quezon City

1121

Novartis Investigative Site, Quezon City

1612

Novartis Investigative Site, Sofia

1709

Novartis Investigative Site, Sofia

1740

Novartis Investigative Site, Las Piñas

3000

Novartis Investigative Site, Leuven

3144

Novartis Investigative Site, Malvern

3600

Novartis Investigative Site, Genk

4114

Novartis Investigative Site, Dasmariñas

4217

Novartis Investigative Site, Lipa City

4558

Novartis Investigative Site, Maroochydore

5400

Novartis Investigative Site, Sevlievo

5800

Novartis Investigative Site, Pleven

9000

Novartis Investigative Site, Ghent

10400

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Bangkok

12203

Novartis Investigative Site, Berlin

16635

Novartis Investigative Site, Duncansville

22143

Novartis Investigative Site, Hamburg

22415

Novartis Investigative Site, Hamburg

28210

Novartis Investigative Site, Charlotte

29204

Novartis Investigative Site, Columbia

29406

Novartis Investigative Site, North Charleston

30263

Novartis Investigative Site, Newnan

31134

Novartis Investigative Site, Hildesheim

33321

Novartis Investigative Site, Tamarac

37067

Novartis Investigative Site, Valeggio sul Mincio

38305

Novartis Investigative Site, Jackson

39245

Novartis Investigative Site, Gommern

39261

Novartis Investigative Site, Zerbst

40002

Novartis Investigative Site, Khon Kaen

40882

Novartis Investigative Site, Ratingen

44649

Novartis Investigative Site, Herne

50200

Novartis Investigative Site, Chiang Mai

50924

Novartis Investigative Site, Cologne

52064

Novartis Investigative Site, Aachen

53100

Novartis Investigative Site, Siena

55121

Novartis Investigative Site, Eagan

59100

Novartis Investigative Site, Prato

63117

Novartis Investigative Site, Richmond Heights

68516

Novartis Investigative Site, Lincoln

73103

Novartis Investigative Site, Oklahoma City

75150

Novartis Investigative Site, Mesquite

75216

Novartis Investigative Site, Dallas

75246

Novartis Investigative Site, Dallas

76126

Novartis Investigative Site, Benbrook

77034

Novartis Investigative Site, Houston

77074

Novartis Investigative Site, Houston

78278

Novartis Investigative Site, Ashkelon

85202

Novartis Investigative Site, Mesa

85253

Novartis Investigative Site, Paradise Valley

90429

Novartis Investigative Site, Nuremberg

91054

Novartis Investigative Site, Erlangen

91056

Novartis Investigative Site, Erlangen

91786

Novartis Investigative Site, Upland

95100

Novartis Investigative Site, Catania

98122

Novartis Investigative Site, Seattle

98401

Novartis Investigative Site, Lučenec

115522

Novartis Investigative Site, Moscow

119074

Novartis Investigative Site, Singapore

150003

Novartis Investigative Site, Yaroslavl

169608

Novartis Investigative Site, Singapore

190068

Novartis Investigative Site, Saint Petersburg

400006

Novartis Investigative Site, Cluj-Napoca

529889

Novartis Investigative Site, Singapore

620028

Novartis Investigative Site, Yekaterinburg

620102

Novartis Investigative Site, Yekaterinburg

650029

Novartis Investigative Site, Kemerovo

700195

Novartis Investigative Site, Iași

3339419

Novartis Investigative Site, Haifa

5266202

Novartis Investigative Site, Ramat Gan

6423906

Novartis Investigative Site, Tel Aviv

36207-5710

Novartis Investigative Site, Anniston

02111

Novartis Investigative Site, Boston

07728

Novartis Investigative Site, Freehold

02919

Novartis Investigative Site, Johnston

C1417EYG

Novartis Investigative Site, Buenos Aires

C1181ACH

Novartis Investigative Site, Caba

C1419AHN

Novartis Investigative Site, Caba

X5000EOC

Novartis Investigative Site, Córdoba

X5016KEH

Novartis Investigative Site, Córdoba

X5022CPU

Novartis Investigative Site, Córdoba

S2000CFJ

Novartis Investigative Site, Rosario

S200BHD

Novartis Investigative Site, Rosario

90610-000

Novartis Investigative Site, Porto Alegre

04023-900

Novartis Investigative Site, São Paulo

04266-010

Novartis Investigative Site, São Paulo

A1B 5E8

Novartis Investigative Site, St. John's

A1C 5B8

Novartis Investigative Site, St. John's

L3Y 3R7

Novartis Investigative Site, Newmarket

N2J 1C4

Novartis Investigative Site, Waterloo

G8Z 1Y2

Novartis Investigative Site, Trois-Rivières

792 01

Novartis Investigative Site, Bruntál

686 01

Novartis Investigative Site, Uherské Hradiště

760 01

Novartis Investigative Site, Zlín

04103

Novartis Investigative Site, Leipzig

15-351

Novartis Investigative Site, Bialystok

02-341

Novartis Investigative Site, Warsaw

Unknown

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Bucharest

921 12

Novartis Investigative Site, Piešťany

E11 1NR

Novartis Investigative Site, London

WS11 2XY

Novartis Investigative Site, Cannock

BD5 0NA

Novartis Investigative Site, Bradford

G12 8TA

Novartis Investigative Site, Glasgow

SE1 9RT

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY